- Home
- FBNC vs VERA Comparison
FBNC vs VERA Comparison
Compare FBNC & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBNC
- VERA
- Stock Information
- Founded
- FBNC 1934
- VERA 2016
- Country
- FBNC United States
- VERA United States
- Employees
- FBNC N/A
- VERA N/A
- Industry
- FBNC Major Banks
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- FBNC Finance
- VERA Health Care
- Exchange
- FBNC Nasdaq
- VERA Nasdaq
- Market Cap
- FBNC 1.7B
- VERA 2.0B
- IPO Year
- FBNC N/A
- VERA 2021
- Fundamental
- Price
- FBNC $46.28
- VERA $24.21
- Analyst Decision
- FBNC Buy
- VERA Buy
- Analyst Count
- FBNC 4
- VERA 8
- Target Price
- FBNC $49.33
- VERA $64.63
- AVG Volume (30 Days)
- FBNC 241.7K
- VERA 1.4M
- Earning Date
- FBNC 07-23-2025
- VERA 08-07-2025
- Dividend Yield
- FBNC 1.90%
- VERA N/A
- EPS Growth
- FBNC N/A
- VERA N/A
- EPS
- FBNC 2.11
- VERA N/A
- Revenue
- FBNC $347,423,000.00
- VERA N/A
- Revenue This Year
- FBNC $34.56
- VERA N/A
- Revenue Next Year
- FBNC $6.35
- VERA N/A
- P/E Ratio
- FBNC $21.95
- VERA N/A
- Revenue Growth
- FBNC N/A
- VERA N/A
- 52 Week Low
- FBNC $31.55
- VERA $18.53
- 52 Week High
- FBNC $50.34
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- FBNC 73.23
- VERA 55.01
- Support Level
- FBNC $46.31
- VERA $22.57
- Resistance Level
- FBNC $47.66
- VERA $24.26
- Average True Range (ATR)
- FBNC 1.13
- VERA 1.20
- MACD
- FBNC 0.46
- VERA 0.13
- Stochastic Oscillator
- FBNC 87.78
- VERA 77.89
About FBNC First Bancorp
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing and investment advisory services.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.